Despite signifi cant clinical research, progress in reducing mesh-related complications (MRCs) post-surgeries has been sluggish, emphasizing the need for innovative tools to enhance biomechanical understanding and improve therapeutic interventions.The TREAT-POP aims to reduce postoperative MRCs, re-operation rates, and healthcare costs. It also aims to assist manufacturers in aligning with FDA recommendations by utilizing biomechanical simulation for safer and more effective clinical procedures. Including biodegradable (BD) implants enhances the potential for personalized and effective treatment of pelvic organ prolapse (POP). |